Group 1 - Gannee Pharmaceutical (603087.SH) reported its Q3 2025 results, with 62 institutional investors holding a total of 80.31 million shares, representing 13.44% of the total share capital [1] - The top ten institutional investors collectively hold 11.13% of the shares, a decrease of 1.13 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, 21 funds increased their holdings, accounting for a 0.67% increase, while 24 funds decreased their holdings, representing a 0.41% decrease [2] - Seven new public funds disclosed their holdings this period, while 384 funds did not disclose their holdings compared to the previous quarter [2] - In the insurance sector, one insurance company, China Life Insurance Co., Ltd., reduced its holdings slightly [2]